Robust estimates of the efficacy of LTP in HAE-nC1-INH are likely to remain elusive because of the challenges of recruiting sufficient numbers of patients with this rare endotype of HAE into placebo-controlled trials.8 The gene discussed is COL18A1; the disease is hereditary angioedema.